Mark E. Schurdak
4Patents
1h-index
11Co-inventors
45Inventor score
Filing activity: Dec 12, 1997 → Apr 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5976813A | Continuous format high throughput screening | Performing Operations; Transporting | 28 | Expired |
| US11253594B2 | Drug combinations for protecting against neuronal cell death | Physics | 0 | Active |
| US10618914B2 | 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity | Human Necessities | 0 | Active |
| US11111253B2 | 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.